Friday, August 17, 2018
 
 
Company News: Page (1) of 1 - 01/23/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Ovation Fertility™ Hires Aaron Harutunian As Director Of Business Development
 
(January 23, 2018)
Ovation Fertility™ Hires Aaron Harutunian As Director Of Business Development

Recognized for his specialized sales and scientific expertise within the field of IVF and reproductive genetics, Harutunian will lead Ovation Fertility's expansion of key service lines. He brings to the growing company a decade of proven success in building high-performing teams that consistently exceed sales targets for in vitro fertilization (IVF) products and services.

Aaron Harutunian to Lead Growth in Genetics, Donor Services, Embryo Storage

The national fertility services provider Ovation Fertility has added Aaron Harutunian to its rapidly growing team as Director of Business Development. Harutunian joined the Ovation Fertility team on January 15, 2018, bringing 10 years of experience in IVF and reproductive genomics.



“We are excited Mr. Harutunian is joining Ovation Fertility's growing ranks of fertility experts," says Nate Snyder, Ovation Fertility's Chief Executive Officer. “Through our discussions, it became clear Mr. Harutunian shares Ovation Fertility's commitment to providing patients and physicians with market-leading healthcare services. As Director of Business Development, Mr. Harutunian will be tasked with growing Ovation Fertility's genetics, donor services and embryo storage service lines."

Harutunian built his career in the fertility field at Genesis Genetics, starting in 2008 as director of preimplantation genetic screening (PGS), a type of genetic testing for aneuploidy screening of embryos. Starting in 2013, he became director of business development and a managing partner for Genesis Genetics, which later became a CooperSurgical company. He most recently served as director of business development and corporate accounts, responsible for identifying and securing new business deals.

“I'm proud to be part of Ovation Fertility's unparalleled team of dedicated experts, whose goal is to improve pregnancy rates and patient care using only the most advanced genetic testing and IVF technologies clinically available," Harutunian says.

Harutunian earned a Bachelor of Science degree in nutritional sciences from Michigan State University, where he worked as a laboratory technician and research scholar, participating in a grant-funded research project to better understand the function of vitamin A during early embryonic development and cardiovascular formation.

Among his many professional affiliations, Harutunian is a member of the American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE) and Pacific Coast Reproductive Society (PCRS). He is also a manager of the American Association of Bioanalysts (AAB) and has served as a speaker at the Southwest Embryology Summit (SWES) and Southern California Assisted Reproductive Biologists (SCARB).

About Ovation Fertility™
Founded in 2015 by a coalition of thought-leading reproductive endocrinologists and scientists, Ovation Fertility is a national fertility service provider offering a suite of state-of-the-art assisted reproductive technology services to hopeful parents, including embryology, andrology and genetic testing, as part of in vitro fertilization. Ovation Fertility partners with physicians who are committed to reducing the average cost of a live birth through IVF by advancing industry standards in fertility treatment. For more information, visit http://www.ovationfertility.com.

Read the full story at http://www.prweb.com/releases/2018/01/prweb15102242.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines